Press Archive 2009
IV Quarter:
10/20/09: DAIICHI SANKYO EUROPE calls for action on World Osteoporosis Day
10/20/09: MorphoSys and DAIICHI SANKYO Forge Alliance to Develop Novel Antibody Therapies
III Quarter:
09/01/09: Ranbaxy introducing osteoporosis drug EVISTA® into the Romanian market
09/01/09: Edoxaban – next generation oral anticoagulant under investigation to help prevent stroke...
07/10/09: DAIICHI SANKYO and Lilly receive U.S. FDA approval for EFFIENT®
II Quarter:
06/09/09: Substantial increase in sales and employee numbers at DAIICHI SANKYO EUROPE in 2008
I Quarter:
03/11/09: DAIICHI SANKYO awarded the “Best Cardiovascular Pipeline”
03/08/09: Time for change - International Womens Day
03/02/09: DAIICHI SANKYO takes over cardiovascular sales force from Merck Serono in Italy
02/23/09: European Commission Approves EFIENT® (prasugrel)
02/16/09: DAIICHI SANKYO appoints Managing Director for Ireland
01/22/09: Blood pressure goal missed by two thirds of patients
Further press information can be found in press archive 2008.
